Atpase inhibitors
Atpase inhibitors has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Jan 28, 2016: “Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Eye Institute and 6 more
- Humans1
What did studies of Atpase inhibitors find?
2Studies of Atpase inhibitors measured 2 outcomes; the most studied are T cell survival (1 study) and effector T cell differentiation (1).
T cell survival
upin human cells1
1 study
T cell survival
upin human cells1
Atpase inhibitors increase T cell survival in human cells.
“Pharmacological inhibition of ATPase activity dampened effector cell differentiation and improved survival”
CellsCD4-positive T cell
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
Cell reports
Effector T cell differentiation
downin human cells1
1 study
Effector T cell differentiation
downin human cells1
Atpase inhibitors decrease effector T cell differentiation in human cells.
“Pharmacological inhibition of ATPase activity dampened effector cell differentiation and improved survival”
CellsCD4-positive T cell
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
Cell reports